Evaluation of biophotonic imaging to estimate bacterial burden in mice infected with highly virulent compared to less virulent Streptococcus pneumoniae serotypes

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 8, 2010, Pages 3155-3160

  Henken, Stefanie ^a   Bohling, Jennifer ^a   Ogunniyi, A David ^b   Paton, James C ^b   Salisbury, Vyvyan C ^c   Welte, Tobias ^a   Maus, Ulrich A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL VIRULENCE; BAGG ALBINO MOUSE; BIOLUMINESCENCE; C57BL 6 MOUSE; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE COURSE; LUNG INFECTION; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; COLONY COUNT, MICROBIAL; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUMINESCENT MEASUREMENTS; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHOTONS; PNEUMONIA, PNEUMOCOCCAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VIRULENCE;

EID: 77955346278     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00310-10     Document Type: Article

References (20)

1. Akins, R. L., and K. K. Haase. 2005. Gram-positive resistance: pathogens, implications, and treatment options: insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy 25:1001-1010.
2. Alloush, H. M., V. Salisbury, R. J. Lewis, and A. P. MacGowan. 2003. Pharmacodynamics of linezolid in a clinical isolate of Streptococcus pneumoniae genetically modified to express lux genes. J. Antimicrob. Chemother. 52:511-513.
3. Beard, S. J., V. Salisbury, R. J. Lewis, J. A. Sharpe, and A. P. MacGowan. 2002. Expression of lux genes in a clinical isolate of Streptococcus pneumoniae: using bioluminescence to monitor gemifloxacin activity. Antimicrob. Agents Chemother. 46:538-542.
4. Contag, C. H., and M. H. Bachmann. 2002. Advances in in vivo bioluminescence imaging of gene expression. Annu. Rev. Biomed. Eng. 4:235-260.
5. Contag, C. H., P. R. Contag, J. I. Mullins, S. D. Spilman, D. K. Stevenson, and D. A. Benaron. 1995. Photonic detection of bacterial pathogens in living hosts. Mol. Microbiol. 18:593-603.
6. Doyle, T. C., S. M. Burns, and C. H. Contag. 2004. In vivo bioluminescence imaging for integrated studies of infection. Cell. Microbiol. 6:303-317.
7. Felmingham, D., R. Canton, and S. G. Jenkins. 2007. Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004. J. Infect. 55:111-118. (Pubitemid 47033820)
8. Hardy, J., K. P. Francis, M. DeBoer, P. Chu, K. Gibbs, and C. H. Contag. 2004. Extracellular replication of Listeria monocytogenes in the murine gall bladder. Science 303:851-853. (Pubitemid 38174666)
9. Henken, S., J. Bohling, J. Martens-Lobenhoffer, J. C. Paton, A. D. Ogunniyi, D. E. Briles, V. C. Salisbury, D. Wedekind, S. M. Bode-Böger, T. Welsh, F. Bange, T. Welte, and U. A. Maus. 2010. Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae. Antimicrob. Agents Chemother. 54:707-717.
10. Hollingshead, M. G., C. A. Bonomi, S. D. Borgel, J. P. Carter, R. Shoemaker, G. Melillo, and E. A. Sausville. 2004. A potential role for imaging technology in anticancer efficacy evaluations. Eur. J. Cancer 40:890-898.
11. Hutchens, M., and G. D. Luker. 2007. Applications of bioluminescence imaging to the study of infectious diseases. Cell. Microbiol. 9:2315-2322.
12. Kadurugamuwa, J. L., K. Modi, O. Coquoz, B. Rice, S. Smith, P. R. Contag, and T. Purchio. 2005. Reduction of astrogliosis by early treatment of pneumococcal meningitis measured by simultaneous imaging, in vivo, of the pathogen and host response. Infect. Immun. 73:7836-7843.
13. Maus, U., K. von Grote, W. A. Kuziel, M. Mack, E. J. Miller, J. Cihak, M. Stangassinger, R. Maus, D. Schlondorff, W. Seeger, and J. Lohmeyer. 2002. The role of CC chemokine receptor 2 in alveolar monocyte and neutrophil immigration in intact mice. Am. J. Respir. Crit. Care Med. 166:268-273.
14. Maus, U. A., M. Backi, C. Winter, M. Srivastava, M. K. Schwarz, T. Ruckle, J. C. Paton, D. Briles, M. Mack, T. Welte, R. Maus, R. M. Bohle, W. Seeger, C. Rommel, E. Hirsch, J. Lohmeyer, and K. T. Preissner. 2007. Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection. Am. J. Respir. Crit. Care Med. 175:958-966.
15. Maus, U. A., K. Waelsch, W. A. Kuziel, T. Delbeck, M. Mack, T. S. Blackwell, J. W. Christman, D. Schlondorff, W. Seeger, and J. Lohmeyer. 2003. Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis. J. Immunol. 170:3273-3278.
16. Mook-Kanamori, B. B., M. S. Rouse, C. I. Kang, D. van de Beek, J. M. Steckelberg, and R. Patel. 2009. Daptomycin in experimental murine pneumococcal meningitis. BMC Infect. Dis. 9:50.
17. Reinert, R. R. 2009. The antimicrobial resistance profile of Streptococcus pneumoniae. Clin. Microbiol. Infect. 15(Suppl. 3):7-11.
18. Wiles, S., K. M. Pickard, K. Peng, T. T. MacDonald, and G. Frankel. 2006. In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect. Immun. 74:5391-5396.
19. Winter, C., W. Herbold, R. Maus, F. Langer, D. E. Briles, J. C. Paton, T. Welte, and U. A. Maus. 2009. Important role for CC chemokine ligand 2-dependent lung mononuclear phagocyte recruitment to inhibit sepsis in mice infected with Streptococcus pneumoniae. J. Immunol. 182:4931-4937.
20. Winter, C., K. Taut, F. Langer, M. Mack, D. E. Briles, J. C. Paton, R. Maus, M. Srivastava, T. Welte, and U. A. Maus. 2007. FMS-like tyrosine kinase 3 ligand aggravates the lung inflammatory response to Streptococcus pneumoniae infection in mice: role of dendritic cells. J. Immunol. 179:3099-3108.